CSMD1 and schizophrenia: Our current results document 15–25% differences in levels of expression of CSMD1 in postmortem brains of individuals with common CSMD1 genotype marker alleles that lie near CSMD1 markers that have been associated with substance dependence, ability to quit smoking and vulnerability to developing schizophrenia.